Clinical Trial Detail

NCT ID NCT02276443
Title Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative
Recruitment Recruiting
Gender both
Phase Phase 0
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

triple-receptor negative breast cancer

Therapies
Age Groups: adult senior

No variant requirements are available.